Proponents of coverage argued treating obesity can reduce longer-term costs by cutting down on heart attacks and other health ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, the Centers for Medicare and Medicaid Services said in a filing published ...

Medicare Advantage insurers had urged CMS to scrap the obesity drug coverage proposals and eliminate a health equity payment ...

The Trump administration canceled a Biden-era plan on Friday that would have made Ozempic and other weight-loss drugs ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

The Centres for Medicare and Medicaid Services on Friday said that it did not move forward with a proposal put forward by the ...

The Centers for Medicare & Medicaid Services will not cover drugs when exclusively used for weight loss, like Ozempic or Wegovy, the Trump administration announced.

Health and Human Services Secretary Robert F. Kennedy Jr. has been a vocal critic of drugs like Ozempic which he said cloud ...

The Centers for Medicare and Medicaid (CMS) announced Friday it will not be finalizing a rule proposed by the Biden ...

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...

The Senate confirmed Dr. Mehmet Oz is a party line 53-45 vote to lead the Centers for Medicare and Medicaid Services.